Skip to main content
Have a personal or library account? Click to login
Enrofloxacin decreases IL-6 and TNF-α production by lipopolysaccharide-stimulated porcine peripheral blood mononuclear cells Cover

Enrofloxacin decreases IL-6 and TNF-α production by lipopolysaccharide-stimulated porcine peripheral blood mononuclear cells

Open Access
|May 2016

References

  1. 1. Araujo F.G., Slifer T.L., Remington J.S.: Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide. Clin Microbiol Infect 2002, 8, 26–30.
  2. 2. Bailly S., Fay M., Ferrua B., Gougerot-Pocidalo M.A.: Ciprofloxacin treatmentincreases thecapacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alpha. Clin Exp Immunol 1991, 85, 331–334.
  3. 3. Bazzoni F., Beutler B.: The tumor necrosis factor ligand and receptor families. New Engl J Med 1996, 334, 1717–1725.
  4. 4. Chirigos N.A., De Simone C.: Immunoregulatory biological response modifiers: effect of cytokines on septic shock. Mediators Inflam 1993, 2, 5–10.
  5. 5. Choi I.S., Collisson E.W., Maheswaran S.K., Yoo H.S.: Evaluation of cytokine gene expression in porcine spleen cells, peripheral blood mononuclear cells, and alveolar macrophages by competitive RT-PCR. FEMS Immunol Med Microbiol 2002, 34, 119–126.
  6. 6. Dalhoff A.: Immunomodulatory activities of fluoroquinolones. Infection 2005, 33, 255–270.
  7. 7. Gattoni A., Parlato A., Vangieri B., Bresciani M., Derna R.: Interferon-gamma: biologic functions and HCV therapy (type I/II). Clin Therap 2006, 157, 377–386.
  8. 8. Khalifeh M.S., Amawi M.M., Abu-Basha E.A., Bani Yonis I.: Assessment of humoral and cellular-mediated immune response in chickens treated with tilmicosin, florfenicol or enrofloxacin at the time of Newcastle disease vaccination. Poultry Sci 2009, 88, 2118–2124.
  9. 9. Khan A.A., Slifer T.R., Remington J.S.: Effect of trovafloxacin on production of cytokines by human monocytes. Antimicrob Agent Chemother 1998, 42, 1713–1717.
  10. 10. Koma-Komai M., Gilchrist D.S., Xu D.: Direct recognition of LPS by human but not murine CD8+ T cellsTLR4 complex. Eur J Immunol 2009, 39, 1564–1572.
  11. 11. Lauder S.N., Jones E., Smart K., Bloom A., Williams A.S., Hindle J.P., Ondondo B., Taylor P.R., Clement M., Fielding C., Godkin A.J., Jones S.A., Gallimore A.M.: Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology. Eur J Immunol 2013, 43, 2613–2625.
  12. 12. Marsh C.B., Wewers M.D.: The pathogenesis of sepsis. Factors that modulate the response to gram-negative bacterial infection. Clin Chest Med 1996, 7, 183–197.
  13. 13. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A.: Interleukin–10 and the interleukin-10 receptor. Ann Rev Immunol 2001, 19, 683–765.
  14. 14. Morikawa K., Watabe H., Araake M., Morikawa S.: Modulatory effect of antibiotics on cytokine production by human monocytes. Antimicrob Agent Chemother 1996, 40, 1366–1370.
  15. 15. Opal S.M., Esmon C.T.: Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Critical Care 2003, 7, 23–38.
  16. 16. Parveen Y., Calder P.C.: Cytokine production by human peripheral blood mononuclear cells: differential sensitivity to glutamine availability. Cytokine 1998, 10, 790–794.
  17. 17. Pomorska-Mól M., Kwit K., Markowska-Daniel I., Pejsak Z.: The effect of doxycycline treatment on the postvaccinal immune response in pigs. Toxicol Appl Pharmacol 2014, 278, 31–38.
  18. 18. Pomorska-Mól M., Markowska-Daniel I., Kwit K., Czyżewska E., Dors A., Rachubik J., Pejsak Z.: Immune and inflammatory response in pigs during acute influenza caused by H1N1 swine influenza virus. Arch Virol 2014, 159, 2605–2614.
  19. 19. Purswani M.U., Eckert S.J., Arora H.K., Moel G.J.: Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine response in a murinemodel. J Antimicrob Chemother 2002, 50, 51–58.
  20. 20. Schoevers E.J., van Leengoed L.A.M.G., Verheijden J.H.M., Niewold T.A.: Effects of enrofloxacin on porcine phagocytic function. Antimicrob Agent Chemother 1999, 43, 2138–2143.
  21. 21. Shalit I., Halperin D., Haite D., Levitov A., Romano J., Osherov N., Fabian I.: Anti-inflammatory effects of moxifloxacin on IL-8, IL-1beta and TNF-alpha secretion and NFkappaB and MAP–kinase activation in human monocytes stimulated with. J Antimicrob Chemother 2006, 57, 230–235.
  22. 22. Tsivkovskii R., Sabet M., Tarazi Z., Griffith D.C., Lomovskaya O., Dudley M.N.: Levofloxacin reduces inflammatory cytokine levels in human bronchial epithelia cells: implications for aerosol MP-376 (levofloxacin solution for inhalation) treatment of chronic pulmonary infections. FEMS Immunol Med Microbiol 2011, 61, 141–146.
  23. 23. Vaure C., Liu Y.: A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol 2014, 5, 316.
  24. 24. Williams A.C., Galley H.F., Watt A.M., Webster N.R.: Differential effects of three antibiotics on T helper cell cytokine expression. J Antimicrob Chemother 2005, 56, 502–506.
  25. 25. Ziółkowski H., Jaroszewski J.J., Maślanka T., Grabowski T., Katolik K., Pawęska J., Siemianowska M., Jasiecka A., Markiewicz W., Spodniewska A.: Influence of oral co-administration of a preparation containing calcium and magnesium and food on enrofloxacin pharmacokinetics. Res Vet Sci 2014, 7, 99–104.
DOI: https://doi.org/10.1515/jvetres-2016-0028 | Journal eISSN: 2450-8608 (formerly 2300-3235)
Language: English
Page range: 189 - 193
Submitted on: Jan 27, 2016
Accepted on: May 10, 2016
Published on: May 28, 2016
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services

© 2016 Małgorzata Pomorska-Mól, Ewelina Czyżewska-Dors, Krzysztof Kwit, Zygmunt Pejsak, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.